Bos taurus Gene: CYLD | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||
InnateDB Gene | IDBG-631654.3 | ||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||
Gene Symbol | CYLD | ||||||||||||||||||||||||
Gene Name | Ubiquitin carboxyl-terminal hydrolase CYLD | ||||||||||||||||||||||||
Synonyms | |||||||||||||||||||||||||
Species | Bos taurus | ||||||||||||||||||||||||
Ensembl Gene | ENSBTAG00000006291 | ||||||||||||||||||||||||
Encoded Proteins |
Ubiquitin carboxyl-terminal hydrolase CYLD
|
||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||
Useful resources | Stemformatics EHFPI ImmGen | ||||||||||||||||||||||||
InnateDB Annotation from Orthologs | |||||||||||||||||||||||||
Summary |
[Homo sapiens] CYLD is a negative regulator of DDX58(RIG-I)-mediated antiviral response by removing Lys 63-linked polyubiquitin chains from RIG-I and TBK1.
[Homo sapiens] CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia.
[Homo sapiens] CYLD is a deubiquitinase that counteracts E3 ligases and therefore play a prominent role in the downregulation of NF-κB signalling and homeostasis.
[Homo sapiens] CYLD is a deubiquitinase that act as a negative regulator of TLR3 induction in response to LPS.
[Homo sapiens] CYLD plays a key role in Type I IFN receptor signalling during vesicular stomatitis virus (VSV) infection. In the absence of CYLD, IFN-beta is ineffective in the induction of antiviral genes. (Demonstrated in mice)
[Homo sapiens] The E3 ligase ITCH and deubiquitinase CYLD act together to regulate TAK1 and inflammation.
[Homo sapiens] MIR362 promotes natural killer-cell function by the down-regulation of CYLD.
[Mus musculus] Cyld is a deubiquitinase that act as a negative regulator of TLR3 induction in response to LPS. (Demonstrated in human)
[Mus musculus] Cyld plays a key role in Type I IFN receptor signalling during vesicular stomatitis virus (VSV) infection. In the absence of Cyld, IFN-beta is ineffective in the induction of antiviral genes.
[Mus musculus] The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
|
||||||||||||||||||||||||
Entrez Gene | |||||||||||||||||||||||||
Summary |
This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000083799:
This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008] |
||||||||||||||||||||||||
Gene Information | |||||||||||||||||||||||||
Type | Protein coding | ||||||||||||||||||||||||
Genomic Location | Chromosome 18:19224240-19293983 | ||||||||||||||||||||||||
Strand | Forward strand | ||||||||||||||||||||||||
Band | |||||||||||||||||||||||||
Transcripts |
|
||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 48 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||
Orthologs | |||||||||||||||||||||||||
Species
Homo sapiens
Mus musculus
|
Gene ID
Gene Order
|
||||||||||||||||||||||||
Pathways | |||||||||||||||||||||||||
NETPATH | |||||||||||||||||||||||||
REACTOME |
NOD1/2 Signaling Pathway pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
Immune System pathway
Negative regulators of RIG-I/MDA5 signaling pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
Innate Immune System pathway
|
||||||||||||||||||||||||
KEGG | |||||||||||||||||||||||||
INOH | |||||||||||||||||||||||||
PID NCI | |||||||||||||||||||||||||
Pathway Predictions based on Human Orthology Data | |||||||||||||||||||||||||
NETPATH |
EGFR1 pathway
RANKL pathway
|
||||||||||||||||||||||||
REACTOME |
Negative regulators of RIG-I/MDA5 signaling pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
NOD1/2 Signaling Pathway pathway
Innate Immune System pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
Immune System pathway
Innate Immune System pathway
Negative regulators of RIG-I/MDA5 signaling pathway
Immune System pathway
NOD1/2 Signaling Pathway pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
|
||||||||||||||||||||||||
KEGG |
RIG-I-like receptor signaling pathway pathway
Osteoclast differentiation pathway
RIG-I-like receptor signaling pathway pathway
Osteoclast differentiation pathway
|
||||||||||||||||||||||||
INOH | |||||||||||||||||||||||||
PID NCI |
TNF receptor signaling pathway
Canonical NF-kappaB pathway
|
||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||
SwissProt | Q1RMU2 | ||||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||
Entrez Gene | 536421 | ||||||||||||||||||||||||
UniGene | Bt.58637 | ||||||||||||||||||||||||
RefSeq | NM_001046417 XM_005218683 XM_005218684 XM_005218685 | ||||||||||||||||||||||||
HUGO | |||||||||||||||||||||||||
OMIM | |||||||||||||||||||||||||
CCDS | |||||||||||||||||||||||||
HPRD | |||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||
EMBL | BC114710 | ||||||||||||||||||||||||
GenPept | AAI14711 | ||||||||||||||||||||||||
RNA Seq Atlas | 536421 | ||||||||||||||||||||||||